Anti-inflammatory strategy stops aggressive childhood cancer
- OPACC
- May 29, 2018
- 1 min read
Researchers at Karolinska Institutet and Karolinska University Hospital have discovered that an anti-inflammatory drug candidate inhibiting the prostaglandin E2 producing enzyme mPGES-1 in the tumour stroma reduces tumour growth in experimental neuroblastoma models.
Comentarios